Delivery Order SPE2DB22D3004-SPE2DB25FPK16
Award Date
2/4/25
Potential Completion Date
2/26/25
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,862.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Zeposia 0.92 MG Capsule 30S, with a completion date of May 1, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,799.42 delivery order is for the medication Zeposia 0.92 MG Capsule 30S and has a completion date of May 14, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to military healthcare...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication Zeposia 0.92 mg Capsule 30s, with a ceiling value of $13,862.79 and a performance period through May 21, 2025. This contract is not set-aside and was awarded as part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPU60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of March 27, 2025, is for the delivery of Zeposia 0.92 mg capsules, a medical product, at a ceiling value of $4,620.93. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $4,620.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of the medication Zeposia 0.92 mg capsule 30s, a prescription drug used for the treatment of certain medical conditions. The contract is a delivery order with a firm fixed price and an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zeposia 0.92 MG Capsule 30S, a pharmaceutical product. The contract has a ceiling value of $18,483.72 and a completion date of February 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zeposia 0.92 MG Capsule 30S, a medication, with a ceiling value of $9,241.86 and an ultimate completion date of January 22, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm fixed price delivery order is for the supply of Zeposia 0.92 MG Capsule 30S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $13,399.71, is for the supply of Zeposia 0.92 mg capsules. Zeposia is a prescription medication used to treat certain medical conditions. The delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award, identified as SPE2DX15D1053|SPE2DX25F6MKD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,862.79 firm fixed-price delivery order is for the supply of the medication Zeposia 0.92 MG Capsule 30S. This award is not a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) vehicle, SPE2DX, held by AmerisourceBergen Drug Corp with the DLA Troop Support...